Description
Dual GIP / GLP-1 Receptor Agonist. Tirzepatide is a synthetic dual-receptor agonist peptide widely referenced in research literature examining incretin receptor signalling and peptide stability. Supplied as a lyophilised research material for laboratory use only.
Key Characteristics
Verification
Independently assayed at 99.55% HPLC purity by an accredited external laboratory prior to release.
Presentation
Lyophilised white powder, sealed under vacuum. Supplied in a 10 MG vial.
Traceability
Batch TZ10-0731. Every vial traces back to the exact analysis that cleared its batch.
Technical Properties
Handling & Storage
Store the sealed vial cool, dry and away from direct light. Handle only in a controlled laboratory setting using appropriate protective equipment. Handling guidance is included with every order.
Compliance
For laboratory and research use only. Not for human or animal consumption. This product is not a therapeutic good, drug, supplement, food product or cosmetic.
Further Reading
For a fuller explanation of what Tirzepatide is, what the published literature covers and how its analytical documentation works, see our Tirzepatide research guide.
Reviews
There are no reviews yet.